Clinical aspects of bleeding complications in cirrhotic patients

被引:25
作者
Craxì, A
Cammà, C
Giunta, M
机构
[1] Univ Palermo, Ist Med Clin, I-90133 Palermo, Italy
[2] CNR, Ist Metodol Diagnost Avanzate, Palermo, Italy
关键词
cirrhosis; portal hypertension; variceal haemorrhage; haemostasis; rFVIIa;
D O I
10.1097/00001721-200004001-00015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Liver disease is a frequent cause of haemostatic abnormalities, which may lead to overt or occult bleeding. Clinical manifestations of hepatic coagulopathy include upper and lower gastrointestinal haemorrhage, easy bruising and bleeding from gums, nose or the female genital tract. The most significant bleeding problem among patients with chronic liver disease is blood loss due to portal hypertension. About 30% of subjects with oesophageal or gastric varices resulting from cirrhosis have an episode of gastrointestinal bleeding in their lifetime. Risk factors for the first episode of variceal bleeding include the severity of liver dysfunction, large varices, and the presence of endoscopic red colour signs. Bacterial infection in patients with variceal haemorrhage may be critical in triggering bleeding. Nongastrointestinal bleeding events, either spontaneous or induced by minor trauma, are also a common complication of advanced cirrhosis. In women, for instance, dysfunctional uterine bleeding may become so severe that hysterectomy is required. In addition, invasive diagnostic tests (mostly solid tissue biopsies) and surgical procedures have a high risk of haemorrhage and are sometimes withheld in cirrhotic patients for fear of complications. In patients with portal hypertension, surgical procedures aggravate the injury of the hepatic parenchyma and may worsen the condition. Blood Coagul Fibrinolysis 11 (suppl 1):S75-S79 (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:S75 / S79
页数:5
相关论文
共 24 条
[1]  
ALEDORT L M, 1976, P350
[2]   THE NATURAL HISTORY OF ESOPHAGEAL VARICES - A STUDY OF 115 CIRRHOTIC PATIENTS IN WHOM VARICES WERE DIAGNOSED PRIOR TO BLEEDING [J].
BAKER, LA ;
SMITH, C ;
LIEBERMAN, G .
AMERICAN JOURNAL OF MEDICINE, 1959, 26 (02) :228-237
[3]   Bleeding time does not predict gastrointestinal bleeding in patients with cirrhosis [J].
Basili, S ;
Ferro, D ;
Leo, R ;
Juliano, L ;
Alessandri, C ;
Cordova, C ;
Violi, F ;
Quintarilli, C ;
Vezza, E ;
Saliola, M ;
Lugara, C ;
Vieri, M ;
Cara, D ;
Massafra, S ;
Pettirossi, G ;
Paradiso, M .
JOURNAL OF HEPATOLOGY, 1996, 24 (05) :574-580
[4]  
Bernard B, 1997, HEPATOLOGY, V25, P63, DOI 10.1053/jhep.1997.v25.pm0008985266
[5]   Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta-analysis [J].
Bernard, B ;
Lebrec, D ;
Mathurin, P ;
Opolon, P ;
Poynard, T .
JOURNAL OF HEPATOLOGY, 1997, 26 (02) :312-324
[6]   Medical treatment of portal hypertension [J].
Bosch, J .
DIGESTION, 1998, 59 (05) :547-555
[7]   Optimizing emergency care of upper gastrointestinal bleeding in cirrhotic patients [J].
Burroughs, AK ;
Planas, R ;
Svoboda, P .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1998, 33 :14-24
[8]  
CHRISTENSEN E, 1981, GASTROENTEROLOGY, V81, P944
[9]   SURVIVAL AND PROGNOSTIC INDICATORS IN COMPENSATED AND DECOMPENSATED CIRRHOSIS [J].
DAMICO, G ;
MORABITO, A ;
PAGLIARO, L ;
MARUBINI, E .
DIGESTIVE DISEASES AND SCIENCES, 1986, 31 (05) :468-475
[10]  
DEFRANCHIS R, 1988, NEW ENGL J MED, V319, P983